The epidermal growth factor-like domain of CD93 is a potent angiogenic factor. 2012

Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Human CD93, an epidermal growth factor (EGF)-like domain containing transmembrane protein, is predominantly expressed in the vascular endothelium. Studies have shown that AA4, the homolog of CD93 in mice, may mediate cell migration and angiogenesis in endothelial cells. Soluble CD93 has been detected in the plasma of healthy individuals. However, the role of soluble CD93 in the endothelium remains unclear. Recombinant soluble CD93 proteins with EGF-like domains (rCD93D123, with domains 1, 2, and 3; and rCD93D23, with domains 2 and 3) were generated to determine their functions in angiogenesis. We found that rCD93D23 was more potent than rCD93D123 in stimulating the proliferation and migration of human umbilical vein endothelial cells (HUVECs). Production of matrix-metalloproteinase 2 increased after the HUVECs were treated with rCD93D23. Further, in a tube formation assay, rCD93D23 induced cell differentiation of HUVECs through phosphoinositide 3-kinase/Akt/endothelial nitric oxide synthase and extracellular signal-regulated kinases-1/2 signaling. Moreover, rCD93D23 promoted blood vessel formation in a Matrigel-plug assay and an oxygen-induced retinopathy model in vivo. Our findings suggest that the soluble EGF-like domain containing CD93 protein is a novel angiogenic factor acting on the endothelium.

UI MeSH Term Description Entries
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D011951 Receptors, Complement Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. Complement Receptors,Complement Receptor,Complement Receptor Type 1,Receptor, Complement
D012162 Retinal Degeneration A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304) Degeneration, Retinal,Degenerations, Retinal,Retinal Degenerations
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug

Related Publications

Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
June 1986, Science (New York, N.Y.),
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
January 2010, Neuro-Signals,
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
March 2003, Oncogene,
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
May 1993, Hypertension (Dallas, Tex. : 1979),
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
September 1996, Proceedings of the National Academy of Sciences of the United States of America,
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
November 1992, The Journal of cell biology,
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
July 2014, Genesis (New York, N.Y. : 2000),
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
April 2012, Oncology reports,
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
March 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Yuan-Chung Kao, and Shinn-Jong Jiang, and Wen-An Pan, and Kuan-Chieh Wang, and Po-Ku Chen, and Hsi-Ju Wei, and Wei-Sheng Chen, and Bi-Ing Chang, and Guey-Yueh Shi, and Hua-Lin Wu
April 2016, Cancer biotherapy & radiopharmaceuticals,
Copied contents to your clipboard!